What: 15th Northwest Diabetes, Endocrinology and Cardiovascular Update
When: Saturday, 8th Dec 2018
Where: Pendulum Hotel and Manchester Conference Centre, Weston Building, Sackville Street, Manchester, M1 3BB http://www.manchesterconferencecentre.co.uk
The nearest carpark is situated on Charles street http://www.estates.manchester.ac.uk/services/operationalservices/carparking
To register, please complete the registration form on the following website:
https://www.surveymonkey.co.uk/r/CHH6JS5
For queries: northwest.cpd@gmail.com
Applied for 5 CPD points
Organised by Dr Handrean Soran and Dr Naveed Younis
The sponsors have had no involvement in developing the content of the meeting.
The meeting is free for Health Care professionals, scientists and students.
Limited places available, please book your place as soon as possible.
Provisional Programme
| 0830–0900 | Registration & coffee | |
| 0855 | Welcome | Dr Handrean Soran |
| First session | ||
| 0900–0945 | Managing hypertension for general practitioners and physicians
i. When to treat? ii. How to treat? iii. What treatment target? iv. Should we manage hypertension in patients with diabetes differently? v. When to refer to secondary care? |
Professor Anthony Heagerty,
University of Manchester, UK |
| 0945-1030 | Chronic kidney disease
i. The impact of chronic kidney disease ii. Initial assessment of CKD in primary care iii. When to refer patients with CKD to secondary care iv. Diabetes nephropathy When to think beyond diabetes nephropathy? Initial assessment in primary care Should we combine ACEIs and ARBs? |
Professor Philip Kalra,
Salford Royal NHS Foundation Trust |
| 1030-1115 | An update on management of hyperlipidaemia
i. What is new with LDL cholesterol lowering: PCSK9 monoclonal antibodies ii. Hypertriglyceridaemia: how to manage and what is new? iii. Diabetes Dyslipidaemia iv. Statin intolerance |
Dr Handrean Soran,
Manchester University NHS Foundation Trust |
| 1115-1135 | Moderated Panel discussion | |
| 1135–1215 | Sandwich lunch & networking | |
| Second session | ||
| 1215-1300 | Making sense of clinical guidelines for diabetes in a world of obesity
i. Treatment options ii. Managing diabesity iii. When to consider metabolic surgery |
Dr Akheel Syed,
Salford Royal NHS Foundation Trust |
| 1300-1345 | Managing cardiovascular risk in patients with diabetes: Is there a role for glucose lowering agents?
|
Dr Naveed Younis,
Manchester University NHS Foundation Trust |
| 1345-1400 | Nutraceuticals in clinical practice and recent advances | TBC |
| 1410-1430 | Moderated panel discussion | |
| 1430 | End | |
Endodiabesity 